Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Errin Samuëlsz

3PUBLICATIONS

17CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Oct 30, 2024

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of <i>KRAS</i>-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.

Daniel H Ahn, Maya Ridinger, Timothy L Cannon

|Jan 17, 2024

Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study.

Daniel H Ahn, Afsaneh Barzi, Maya Ridinger

|Oct 01, 2020

A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Amer M Zeidan, Maya Ridinger, Tara L Lin

Pageof 1

Frequent Collaborators

3 joint publications

Heinz-Josef Lenz

2 joint publications

Daniel H Ahn

2 joint publications

Afsaneh Barzi

2 joint publications

Maya Ridinger

2 joint publications

Ramanand A Subramanian

2 joint publications

Peter J P Croucher

1 joint publications

Amer M Zeidan

1 joint publications

Tara L Lin

1 joint publications

Pamela S Becker

1 joint publications

Tod Smeal

Frequent Collaborators

3 joint publications

Heinz-Josef Lenz

2 joint publications

Daniel H Ahn

2 joint publications

Afsaneh Barzi

2 joint publications

Maya Ridinger

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos